- Home
- GPCR vs ORC Comparison
GPCR vs ORC Comparison
Compare GPCR & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- ORC
- Stock Information
- Founded
- GPCR 2016
- ORC 2010
- Country
- GPCR United States
- ORC United States
- Employees
- GPCR N/A
- ORC N/A
- Industry
- GPCR
- ORC Real Estate Investment Trusts
- Sector
- GPCR
- ORC Real Estate
- Exchange
- GPCR Nasdaq
- ORC Nasdaq
- Market Cap
- GPCR 1.2B
- ORC 1.0B
- IPO Year
- GPCR 2023
- ORC 2013
- Fundamental
- Price
- GPCR $30.52
- ORC $7.19
- Analyst Decision
- GPCR Strong Buy
- ORC Hold
- Analyst Count
- GPCR 8
- ORC 2
- Target Price
- GPCR $69.57
- ORC N/A
- AVG Volume (30 Days)
- GPCR 1.0M
- ORC 5.4M
- Earning Date
- GPCR 11-12-2025
- ORC 10-23-2025
- Dividend Yield
- GPCR N/A
- ORC 20.03%
- EPS Growth
- GPCR N/A
- ORC N/A
- EPS
- GPCR N/A
- ORC 0.07
- Revenue
- GPCR N/A
- ORC $24,257,000.00
- Revenue This Year
- GPCR N/A
- ORC $75.23
- Revenue Next Year
- GPCR N/A
- ORC $53.72
- P/E Ratio
- GPCR N/A
- ORC $101.44
- Revenue Growth
- GPCR N/A
- ORC N/A
- 52 Week Low
- GPCR $13.22
- ORC $5.69
- 52 Week High
- GPCR $42.57
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- GPCR 72.59
- ORC 54.48
- Support Level
- GPCR $25.67
- ORC $7.06
- Resistance Level
- GPCR $30.93
- ORC $7.28
- Average True Range (ATR)
- GPCR 1.81
- ORC 0.13
- MACD
- GPCR 0.33
- ORC 0.01
- Stochastic Oscillator
- GPCR 94.40
- ORC 75.00
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.